EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity

Gregory Livshits, Alexander Kalinkovich

Ageing Research Reviews · 2023

DOI: 10.1016/j.arr.2023.101852 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2023. Verfasst von Gregory Livshits und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphological Sciences, Adelson School of Medicine, Ariel University, Ariel 4077625, Israel; Department of Anatomy and Anthropology, Sa…. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 455 Literaturangaben. Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid increase in both the lifespan and proportion of older adults is accompanied by the unprecedented rise in age-associated chronic diseases, including sarcopenia and obesity. Aging is also manifested by increased susceptibility to multiple endogenous and exogenous stresses enabling such chronic conditions to develop. Among the main physiological regulators of cellular adaption to various stress stimuli, such as DNA damage, hypoxia, and oxidative stress, are sestrins (Sesns), a family of three evolutionarily conserved proteins, Sesn1, 2, and 3. Age-associated sarcopenia and obesity are characterized by two key processes: (i) accumulation of senescent cells in the skeletal muscle and adipose tissue and (ii) creation of a systemic, chronic, low-grade inflammation (SCLGI). Presumably, failed SCLGI resolution governs the development of these chronic conditions. Noteworthy, Sesns activate senolytics, which are agents that selectively eliminate senescent cells, as well as specialized pro-resolving mediators, which are factors that physiologically provide inflammation resolution. Sesns reveal clear beneficial effects in pre-clinical models of sarcopenia and obesity. Based on these observations, we propose a novel treatment strategy for age-associated sarcopenia and obesity, complementary to the conventional therapeutic modalities: Sesn activation, SCLGI resolution, and senescent cell elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHumansAgedSestrinsCellular SenescenceAgingObesityInflammationChronic Disease

Stichwörter der Autor:innen

InflammationObesitySarcopeniaSenescenceSestrins

Substanzen

Sestrins

Autor:innen und Institutionen

  • Department of Morphological Sciences, Adelson School of Medicine, Ariel University, Ariel 4077625, Israel; Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6905126, Isra…
  • Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6905126, Israel.

Förderung

  • Israel Science Foundation

Zitieren

APA

Livshits, G., & Kalinkovich, A. (2023). A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2023.101852

Vancouver

Livshits G, Kalinkovich A. A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity. Ageing Research Reviews. 2023. doi:10.1016/j.arr.2023.101852

BibTeX
@article{Livshits2023,
  author = {Livshits, Gregory and Kalinkovich, Alexander},
  title = {A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity},
  journal = {Ageing Research Reviews},
  year = {2023},
  doi = {10.1016/j.arr.2023.101852}
}
Kostenlos starten →